{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:47:12Z","timestamp":1760042832223},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1093\/ije\/dyl207","type":"journal-article","created":{"date-parts":[[2006,10,31]],"date-time":"2006-10-31T23:03:25Z","timestamp":1162335805000},"page":"1579-1585","source":"Crossref","is-referenced-by-count":40,"title":["Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993\u20132004"],"prefix":"10.1093","volume":"35","author":[{"given":"Oliver","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,8,30]]},"reference":[{"key":"key\n\t\t\t\t20171012163608_B1","doi-asserted-by":"crossref","unstructured":"Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. Aids2004;18:2295\u2013303.","DOI":"10.1097\/00002030-200411190-00010"},{"key":"key\n\t\t\t\t20171012163608_B2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. The State of the Drugs Problem in Europe. Annual Report 2005. Available at: http:\/\/europa.eu.int."},{"key":"key\n\t\t\t\t20171012163608_B3","doi-asserted-by":"crossref","unstructured":"De Angelis D, Hickman M, Yang S. Estimating long-term trends in the incidence and prevalence of opiate use\/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths. Am J Epidemiol2004;160:994\u20131004.","DOI":"10.1093\/aje\/kwh306"},{"key":"key\n\t\t\t\t20171012163608_B4","doi-asserted-by":"crossref","unstructured":"Fischer B, Rehm J, Kirst M et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health2002;12:228\u201334.","DOI":"10.1093\/eurpub\/12.3.228"},{"key":"key\n\t\t\t\t20171012163608_B5","doi-asserted-by":"crossref","unstructured":"Hulse GK, English DR, Milne E, Holman CD. The quantification of mortality resulting from the regular use of illicit opiates. Addiction1999;94:221\u201329.","DOI":"10.1046\/j.1360-0443.1999.9422216.x"},{"key":"key\n\t\t\t\t20171012163608_B6","doi-asserted-by":"crossref","unstructured":"Bargagli AM, Hickman M, Davoli M et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health2005;16:198\u2013202.","DOI":"10.1093\/eurpub\/cki168"},{"key":"key\n\t\t\t\t20171012163608_B7","doi-asserted-by":"crossref","unstructured":"Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction2002;97:39\u201347.","DOI":"10.1046\/j.1360-0443.2002.00079.x"},{"key":"key\n\t\t\t\t20171012163608_B8","doi-asserted-by":"crossref","unstructured":"Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet1999;353:221\u201326.","DOI":"10.1016\/S0140-6736(98)05356-2"},{"key":"key\n\t\t\t\t20171012163608_B9","unstructured":"Gossop M. Treatment outcomes: what we know and what we need to know: National Treatment Agency for Substance Misuse, 2005."},{"key":"key\n\t\t\t\t20171012163608_B10","doi-asserted-by":"crossref","unstructured":"Caplehorn JR, Drummer OH. Methadone dose and post-mortem blood concentration. Drug Alcohol Rev2002;21:329\u201333.","DOI":"10.1080\/0959523021000023171"},{"key":"key\n\t\t\t\t20171012163608_B11","doi-asserted-by":"crossref","unstructured":"Corkery JM, Schifano F, Ghodse AH, Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol2004;19:565\u201376.","DOI":"10.1002\/hup.630"},{"key":"key\n\t\t\t\t20171012163608_B12","doi-asserted-by":"crossref","unstructured":"Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ1996;313:270\u201372.","DOI":"10.1136\/bmj.313.7052.270"},{"key":"key\n\t\t\t\t20171012163608_B13","doi-asserted-by":"crossref","unstructured":"Gabbay MB, Carnwath T, Ford C, Zador DA. Reducing deaths among drug misusers. BMJ2001;322:749\u201350.","DOI":"10.1136\/bmj.322.7289.749"},{"key":"key\n\t\t\t\t20171012163608_B14","doi-asserted-by":"crossref","unstructured":"Fiellin DA, O'Connor PG. Clinical practice. Office-based treatment of opioid-dependent patients. N Engl J Med2002;347:817\u201323.","DOI":"10.1056\/NEJMcp013579"},{"key":"key\n\t\t\t\t20171012163608_B15","doi-asserted-by":"crossref","unstructured":"Strike CJ, Urbanoski K, Fischer B, Marsh DC, Millson M. Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001. J Addict Dis2005;24:39\u201351.","DOI":"10.1300\/J069v24n01_04"},{"key":"key\n\t\t\t\t20171012163608_B16","doi-asserted-by":"crossref","unstructured":"Ritter A, Di Natale R. The relationship between take-away methadone policies and methadone diversion. Drug Alcohol Rev2005;24:347\u201352.","DOI":"10.1080\/09595230500263939"},{"key":"key\n\t\t\t\t20171012163608_B17","doi-asserted-by":"crossref","unstructured":"Neeleman J, Farrell M. Fatal methadone and heroin overdoses: time trends in England and Wales. J Epidemiol Community Health1997;51:435\u201337.","DOI":"10.1136\/jech.51.4.435"},{"key":"key\n\t\t\t\t20171012163608_B18","doi-asserted-by":"crossref","unstructured":"Cairns A, Roberts IS, Benbow EW. Characteristics of fatal methadone overdose in Manchester, 1985\u201394. BMJ1996;313:264\u201365.","DOI":"10.1136\/bmj.313.7052.264"},{"key":"key\n\t\t\t\t20171012163608_B19","doi-asserted-by":"crossref","unstructured":"Seymour A, Black M, Jay J, Cooper G, Weir C, Oliver J. The role of methadone in drug-related deaths in the west of Scotland. Addiction2003;98:995\u20131002.","DOI":"10.1046\/j.1360-0443.2003.00425.x"},{"key":"key\n\t\t\t\t20171012163608_B20","unstructured":"Department of Health, Scottish Office Department of Health, Welsh Office, Department of Health and Social Services Norther Ireland. Drug Misuse and Dependence\u2014Guidelines on Clinical Managment. London: The Stationery Office, 1999."},{"key":"key\n\t\t\t\t20171012163608_B21","unstructured":"Christophersen O, Rooney C, Kelly S. Drug-related mortality: methods and trends. Popul Trends1998;Autumn:29\u201337."},{"key":"key\n\t\t\t\t20171012163608_B22","unstructured":"Mwenda L, Ahmad M, Kumari K. Findings 265. Seizures of drugs in England and Wales, 2003. Home Office, 2005."},{"key":"key\n\t\t\t\t20171012163608_B23","doi-asserted-by":"crossref","unstructured":"Strang J, Sheridan J. Effect of government recommendations on methadone prescribing in South East England: comparison of 1995 and 1997 surveys. BMJ1998;317:1489\u201390.","DOI":"10.1136\/bmj.317.7171.1489"},{"key":"key\n\t\t\t\t20171012163608_B24","unstructured":"Strang J, Sheridan J, Hunt C, Kerr B, Gerada C, Pringle M. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales. Br J Gen Pract2005;55:444\u201351."},{"key":"key\n\t\t\t\t20171012163608_B25","unstructured":"Ghodse AH, Corkery JM, Schifano F, Oyefeso A, Bannister D, Annan J. National Programme on Subtsance Abuse Deaths (np-SAD)\u2014Annual Report 2005. St George's, University of London, 2005."},{"key":"key\n\t\t\t\t20171012163608_B26","doi-asserted-by":"crossref","unstructured":"Milroy CM, Forrest AR. Methadone deaths: a toxicological analysis. J Clin Pathol2000;53:277\u201381.","DOI":"10.1136\/jcp.53.4.277"},{"key":"key\n\t\t\t\t20171012163608_B27","unstructured":"United Nations Office on Drugs and Crime. World Drugs Report 2005. New York: United Nations, 2005."},{"key":"key\n\t\t\t\t20171012163608_B28","doi-asserted-by":"crossref","unstructured":"Gibson A, Degenhardt L, Day C, McKetin R. Recent trends in heroin supply to markets in Australia, the United States and Western Europe. Int J Drugs Policy2005;16:293\u201399.","DOI":"10.1016\/j.drugpo.2005.07.001"},{"key":"key\n\t\t\t\t20171012163608_B29","doi-asserted-by":"crossref","unstructured":"Roxburgh A, Degenhardt L, Breen C. Changes in patterns of drug use among injecting drug users following changes in the availability of heroin in New South Wales, Australia. Drug Alcohol Rev2004;23:287\u201394.","DOI":"10.1080\/09595230412331289446"},{"key":"key\n\t\t\t\t20171012163608_B30","doi-asserted-by":"crossref","unstructured":"Degenhardt L, Day C, Gilmour S, Hall W. Patterns of illicit drug use in NSW, Australia following a reduction in heroin supply. Int J Drugs Policy2005;16:300\u201307.","DOI":"10.1016\/j.drugpo.2005.05.008"},{"key":"key\n\t\t\t\t20171012163608_B31","doi-asserted-by":"crossref","unstructured":"Fountain J, Strang J, Gossop M, Farrell M, Griffiths P. Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction2000;95:393\u2013406.","DOI":"10.1046\/j.1360-0443.2000.95339310.x"},{"key":"key\n\t\t\t\t20171012163608_B32","doi-asserted-by":"crossref","unstructured":"Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev2003:CD002208.","DOI":"10.1002\/14651858.CD002208"},{"key":"key\n\t\t\t\t20171012163608_B33","unstructured":"National Audit Office. Changing habits. The commissioning and management of community drug treatment services for adults. Audit Commission, 2002."},{"key":"key\n\t\t\t\t20171012163608_B34","unstructured":"The Task Force to Review Services for Drug Misusers. Report of an Independent Review of Drug Treatment Services in England. Department of Health, 1996."},{"key":"key\n\t\t\t\t20171012163608_B35","doi-asserted-by":"crossref","unstructured":"Strang J, Sheridan J. Methadone prescribing to opiate addicts by private doctors: comparison with NHS practice in south east England. Addiction2001;96:567\u201376.","DOI":"10.1046\/j.1360-0443.2001.9645675.x"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/35\/6\/1579\/1878397\/dyl207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T23:46:34Z","timestamp":1555890394000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ije\/article\/35\/6\/1579\/660043\/Association-between-availability-of-heroin-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,30]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,8,30]]},"published-print":{"date-parts":[[2006,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyl207","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,12]]},"published":{"date-parts":[[2006,8,30]]}}}